Quarterly Statement Of Cash Flows

Mochida Pharmaceutical Co.,Ltd. - Filing #7555476

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
11,173,000,000 JPY
12,925,000,000 JPY
Interest and dividends received
340,000,000 JPY
286,000,000 JPY
Income taxes paid
-3,224,000,000 JPY
-3,616,000,000 JPY
Net cash provided by (used in) operating activities
7,297,000,000 JPY
7,459,000,000 JPY
Cash flows from investing activities
Purchase of securities
-10,500,000,000 JPY
-10,500,000,000 JPY
Proceeds from sale of securities
10,500,000,000 JPY
6,000,000,000 JPY
Proceeds from sale of property, plant and equipment
0 JPY
0 JPY
Purchase of investment securities
JPY
-540,000,000 JPY
Proceeds from sale of investment securities
JPY
538,000,000 JPY
Other, net
316,000,000 JPY
-8,000,000 JPY
Net cash provided by (used in) investing activities
-2,949,000,000 JPY
-2,007,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-3,512,000,000 JPY
-2,511,000,000 JPY
Dividends paid
-3,372,000,000 JPY
-3,445,000,000 JPY
Other, net
0 JPY
0 JPY
Net cash provided by (used in) financing activities
-6,884,000,000 JPY
-5,956,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
32,000,000 JPY
31,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-2,504,000,000 JPY
-472,000,000 JPY
Cash and cash equivalents
38,010,000,000 JPY
40,515,000,000 JPY
40,987,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.